ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Ovarian Cancer trials near Taipei City, TWN:

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) (DO-01)

in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...

Enrolling
Ovarian Cancer
Drug: Trastuzumab Deruxtecan
Drug: Bevacizumab

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Taipei, Taiwan and 207 other locations

Locations recently updated

Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV90 ...

Enrolling
Ovarian Cancer
Drug: Carboplatin
Drug: ABBV-901

Phase 1

AbbVie
AbbVie

Taipei, Taiwan and 21 other locations

choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expressio...

Enrolling
Ovarian Cancer
Drug: Azenosertib
Drug: Investigator's choice of Chemotherapy

Phase 3

K-Group Beta

Taipei, Taiwan and 58 other locations

(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...

Enrolling
Epithelial Ovarian Cancer
Drug: Topotecan
Drug: Mirvetuximab Soravtansine (MIRV)

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 298 other locations

with or without bevacizumab compared to standard of care (SoC) as maintenance treatment in participants with platinum-sensitive relapsed ovarian...

Begins enrollment this month
Platinum-sensitive Relapsed Fallopian Tube Cancer
Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Drug: Bevacizumab
Drug: Torvutatug samrotecan

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 78 other locations

"study drug". The study is focused on participants who have advanced ovarian cancer.The aim of the study is to see how safe, tolera...

Enrolling
Primary Peritoneal Cancer
Fallopian Tube Cancer
Drug: Bevacizumab
Drug: Sarilumab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Taipei, Taiwan and 55 other locations

Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as muc...

Enrolling
Ovarian Neoplasms
Ovarian Cancer
Drug: Sacituzumab tirumotecan
Drug: Bevacizumab

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Taipei, Taiwan and 162 other locations

cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian...

Active, not recruiting
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Drug: Paclitaxel
Biological: Placebo

Phase 3

CanariaBio

Taipei, Taiwan and 149 other locations

This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer...

Enrolling
Solid Cancer
Drug: PLD
Drug: R-DXd

Phase 2, Phase 3

Daiichi Sankyo
Daiichi Sankyo

Taipei, Taiwan and 163 other locations

following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...

Active, not recruiting
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Drug: Placebo Oral Tablet
Drug: Nivolumab

Phase 3

pharmaand

Taipei, Taiwan and 237 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems